205 related articles for article (PubMed ID: 33672006)
1. Curcumin Encapsulated in Crosslinked Cyclodextrin Nanoparticles Enables Immediate Inhibition of Cell Growth and Efficient Killing of Cancer Cells.
Möller K; Macaulay B; Bein T
Nanomaterials (Basel); 2021 Feb; 11(2):. PubMed ID: 33672006
[TBL] [Abstract][Full Text] [Related]
2. Curcumin-cyclodextrin encapsulated chitosan nanoconjugates with enhanced solubility and cell cytotoxicity.
Popat A; Karmakar S; Jambhrunkar S; Xu C; Yu C
Colloids Surf B Biointerfaces; 2014 May; 117():520-7. PubMed ID: 24698148
[TBL] [Abstract][Full Text] [Related]
3. An enzyme-mediated controlled release system for curcumin based on cyclodextrin/cyclodextrin degrading enzyme.
Roozbehi S; Dadashzadeh S; Sajedi RH
Enzyme Microb Technol; 2021 Mar; 144():109727. PubMed ID: 33541570
[TBL] [Abstract][Full Text] [Related]
4.
Zhang L; Yang S; Wong LR; Xie H; Ho PC
Mol Pharm; 2020 Nov; 17(11):4256-4269. PubMed ID: 33084343
[TBL] [Abstract][Full Text] [Related]
5. Antioxidant, antibacterial and anti-cancer activities of β-and γ-CDs/curcumin loaded in chitosan nanoparticles.
Alizadeh N; Malakzadeh S
Int J Biol Macromol; 2020 Mar; 147():778-791. PubMed ID: 31982535
[TBL] [Abstract][Full Text] [Related]
6. Polymeric Nano-Encapsulation of Curcumin Enhances its Anti-Cancer Activity in Breast (MDA-MB231) and Lung (A549) Cancer Cells Through Reduction in Expression of HIF-1α and Nuclear p65 (Rel A).
Khan MN; Haggag YA; Lane ME; McCarron PA; Tambuwala MM
Curr Drug Deliv; 2018 Feb; 15(2):286-295. PubMed ID: 29065834
[TBL] [Abstract][Full Text] [Related]
7. Cyclodextrin-based metal-organic framework nanoparticles as superior carriers for curcumin: Study of encapsulation mechanism, solubility, release kinetics, and antioxidative stability.
Chen Y; Su J; Dong W; Xu D; Cheng L; Mao L; Gao Y; Yuan F
Food Chem; 2022 Jul; 383():132605. PubMed ID: 35413760
[TBL] [Abstract][Full Text] [Related]
8. Application of γ-cyclodextrin-lysozyme as host materials for encapsulation of curcumin: characterization, stability, and controlled release properties.
Wen H; Zhang D; Liu J; Shang X; Liu X; Du Z; Zhang T
J Sci Food Agric; 2022 Oct; 102(13):5925-5934. PubMed ID: 35437803
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of IL-1β release from macrophages targeted with necrosulfonamide-loaded porous nanoparticles.
Boersma B; Möller K; Wehl L; Puddinu V; Huard A; Fauteux-Daniel S; Bourquin C; Palmer G; Bein T
J Control Release; 2022 Nov; 351():989-1002. PubMed ID: 36202154
[TBL] [Abstract][Full Text] [Related]
10. Novel T7-Modified pH-Responsive Targeted Nanosystem for Co-Delivery of Docetaxel and Curcumin in the Treatment of Esophageal Cancer.
Deng L; Zhu X; Yu Z; Li Y; Qin L; Liu Z; Feng L; Guo R; Zheng Y
Int J Nanomedicine; 2020; 15():7745-7762. PubMed ID: 33116498
[TBL] [Abstract][Full Text] [Related]
11. pH - Responsive colloidal carriers assembled from β-lactoglobulin and Epsilon poly-L-lysine for oral drug delivery.
Pujara N; Giri R; Wong KY; Qu Z; Rewatkar P; Moniruzzaman M; Begun J; Ross BP; McGuckin M; Popat A
J Colloid Interface Sci; 2021 May; 589():45-55. PubMed ID: 33450459
[TBL] [Abstract][Full Text] [Related]
12. Mucoadhesive zein/beta-cyclodextrin nanoparticles for the buccal delivery of curcumin.
Esposito D; Conte C; d'Angelo I; Miro A; Ungaro F; Quaglia F
Int J Pharm; 2020 Aug; 586():119587. PubMed ID: 32619690
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and Characterization of Curcumin-Functionalized HP-β-CD-Modified GoldMag Nanoparticles as Drug Delivery Agents.
Lian T; Peng M; Vermorken AJ; Jin Y; Luo Z; Van de Ven WJ; Wan Y; Hou P; Cui Y
J Nanosci Nanotechnol; 2016 Jun; 16(6):6258-64. PubMed ID: 27427699
[TBL] [Abstract][Full Text] [Related]
14. Fabrication of curcumin encapsulated PLGA nanoparticles for improved therapeutic effects in metastatic cancer cells.
Yallapu MM; Gupta BK; Jaggi M; Chauhan SC
J Colloid Interface Sci; 2010 Nov; 351(1):19-29. PubMed ID: 20627257
[TBL] [Abstract][Full Text] [Related]
15. Development of curcumin-cyclodextrin/cellulose nanocrystals complexes: New anticancer drug delivery systems.
Ndong Ntoutoume GMA; Granet R; Mbakidi JP; Brégier F; Léger DY; Fidanzi-Dugas C; Lequart V; Joly N; Liagre B; Chaleix V; Sol V
Bioorg Med Chem Lett; 2016 Feb; 26(3):941-945. PubMed ID: 26739777
[TBL] [Abstract][Full Text] [Related]
16. PGMD/curcumin nanoparticles for the treatment of breast cancer.
Kumari M; Sharma N; Manchanda R; Gupta N; Syed A; Bahkali AH; Nimesh S
Sci Rep; 2021 Feb; 11(1):3824. PubMed ID: 33589661
[TBL] [Abstract][Full Text] [Related]
17. Novel γ-cyclodextrin-metal-organic frameworks for encapsulation of curcumin with improved loading capacity, physicochemical stability and controlled release properties.
Chen Y; Tai K; Ma P; Su J; Dong W; Gao Y; Mao L; Liu J; Yuan F
Food Chem; 2021 Jun; 347():128978. PubMed ID: 33444890
[TBL] [Abstract][Full Text] [Related]
18. Design, Preparation and Evaluation of Supramolecular Complexes with Curcumin for Enhanced Cytotoxicity in Breast Cancer Cell Lines.
Abdelkader H; Fatease AA; Fathalla Z; Shoman ME; Abou-Taleb HA; Abourehab MAS
Pharmaceutics; 2022 Oct; 14(11):. PubMed ID: 36365104
[TBL] [Abstract][Full Text] [Related]
19. Targeted anticancer prodrug therapy using dextran mediated enzyme-antibody conjugate and β-cyclodextrin-curcumin inclusion complex.
Roozbehi S; Dadashzadeh S; Mirshahi M; Sadeghizadeh M; Sajedi RH
Int J Biol Macromol; 2020 Oct; 160():1029-1041. PubMed ID: 32479931
[TBL] [Abstract][Full Text] [Related]
20. beta-Cyclodextrin-curcumin self-assembly enhances curcumin delivery in prostate cancer cells.
Yallapu MM; Jaggi M; Chauhan SC
Colloids Surf B Biointerfaces; 2010 Aug; 79(1):113-25. PubMed ID: 20456930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
